Exploring the association between B-group vitamin deficiency and biomarkers for cardiometabolic disorders in patients with insulin resistance and prediabetes/type 2 diabetes mellitus

Introduction. Exploring the role of B-group vitamin deficiencies in patients with cardiometabolic disorders is important today.

Aim. To study changes in biomarkers for cardiometabolic risk in patients with B-group vitamin deficiencies with underlying insulin resistance and carbohydrate metabolism disorders.

Materials and methods. Seventy patients with abdominal obesity combined with prediabetes or type 2 diabetes were included, 35 of whom received Neuromultivit, 1 tablet twice a day, and 35 patients with abdominal obesity combined with prediabetes or type 2 diabetes who only received a backbone therapy. The observation period was 12 weeks. All patients underwent a preand post-observation examinations, including blood chemistry tests (C-reactive protein, lipid profile, glucose, HbA1C, insulin, homocysteine, B1, B6, and B12 vitamins) and neuropsychological testing such as MoCA test, Schulte Table test, and the Clinical Global Impression (CGI) -based assessment.

Results. During Neuromultivit therapy, improvements were noted in the following parameters: a 0.6 [0.4; 0.9] ng/ml increase in vitamin B1 level (p < 0.001), a 4.6 [3.7; 7.7] ng/m increase in vitamin B6 level (p < 0.001), B12 level by + 256 [202; 474] pg/ml (p < 0.001); homocysteine level decreased by -2.2 [-2.5; -1.6] μmol/l (p < 0.001), glucose level by 0.17 [-0.23; -0.12] mmol/l (p < 0.001); HbA1c level by -0.04 [-0.05; -0.04] % (p = 0.002), insulin level by -0.5 [-0.8; -0.3] μIU/ml (p < 0.001), waist circumference (WC) decreased by -4 [-6; -3] cm (p < 0.001), the MoCA test result improved by +1 [1; 2] score (p < 0.001), the Schulte Table tests showed boosting in speed by -2.1 [-2.3; -1.5] sec, p < 0.001), CGI-I-based assessment demonstrated “significant improvement” in a greater number of patients (p < 0.001). In the control group, no significant positive changes were observed in any of the parameters studied.

Conclusions. Neuromultivit therapy resulted in significant replenishment of B-group vitamin deficiencies, improvement of cardiometabolic parameters and cognitive functioning as compared to the control group.

1. Madan K, Paliwal S, Sharma S, Kesar S, Chauhan N, Madan M. Metabolic syndrome: The constellation of co-morbidities, a global threat. Endocr Metab Immune Disord Drug Targets. 2023;23(12):1491–1504. https://doi.org/10.2174/1871530323666230309144825.

2. Shlyakhto EV, Nedogoda SV, Babenko AYu, Arutyunov GP, Drapkina OM, Kobalava ZhD et al. Concept of an interdisciplinary consensus document on cardiovascular-renal-hepatic-metabolic syndrome. Russian Journal of Cardiology. 2025;30(1S):6533. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6533.

3. Shishkova VN, Martynov AI. Insulin resistance: focus on the pathogenesis of cardiomyopathy. Consilium Medicum. 2020;22(10):52–54. (In Russ.) https://doi.org/10.26442/20751753.2020.10.200341.

4. Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786. https://doi.org/10.3390/ijms23020786.

5. Shishkova VN. Key pathogenetic mechanisms of development of ischemic injury and potentials for their correction in patients with combined cardiovascular diseases. Farmateka. 2015;306(13):64–69. (In Russ.) https://pharmateca.ru/ru/archive/article/31901.

6. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–e1010. https://doi.org/10.1161/CIR.0000000000000973.

7. Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of Metabolic Syndrome and Dietary Intervention. Int J Mol Sci. 2019;20(1):128. https://doi.org/10.3390/ijms20010128.

8. Lyon P, Strippoli V, Fang B, Cimmino L. B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease. Nutrients. 2020;12(9):2867. https://doi.org/10.3390/nu12092867.

9. Pei X, Yao J, Ran S, Lu H, Yang S, Zhang Y, Tan A. Association of serum watersoluble vitamin exposures with the risk of metabolic syndrome: Results from NHANES 2003–2006. Front Endocrinol. 2023;14:1167317. https://doi.org/10.3389/fendo.2023.1167317.

10. Wu Y, Li S, Wang W, Zhang D. Associations of dietary vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12 and folate equivalent intakes with metabolic syndrome. Int J Food Sci Nutr. 2020;71(6):738–749. https://doi.org/10.1080/09637486.2020.1719390.

11. Ashok T, Puttam H, Tarnate VCA, Jhaveri S, Avanthika C, Treviño AGT, Ahmed NT. Role of vitamin B12 and folate in metabolic syndrome. Cureus. 2021;13(10):e18521. https://doi.org/10.7759/cureus.18521.

12. Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarcon-Braga EA, AlKassab-Córdova A, Cabrera-Guzmán JC, Herrera-Añazco P, BenitesZapata VA. Vitamin B12, folate, and homocysteine in metabolic syndrome: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1221259. https://doi.org/10.3389/fendo.2023.1221259.

13. Nurtazina A, Voitsekhovskiy I, Toishimanov M, Dautov D, Karibayev K, Smail Y et al. Exploring the Link Between Vitamin B Levels and Metabolic Syndrome Risk: Insights from a Case-Control Study in Kazakhstan. J Clin Med. 2024;13(23):7206. https://doi.org/10.3390/jcm13237206.

14. Hankey GJ, Ford AH, Yi Q, Eikelboom JW, Lees KR, Chen C et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis. Stroke. 2013;44(8):2232–2239. https://doi.org/10.1161/STROKEAHA.113.001886.

15. Kataria N, Yadav P, Kumar R, Kumar N, Singh M, Kant R, Kalyani V. Effect of vitamin B6, B9, and B12 supplementation on homocysteine level and cardiovascular outcomes in stroke patients: A meta-analysis of randomized controlled trials. Cureus. 2021;13(5):e14958. https://doi.org/10.7759/cureus.14958.

16. Satapathy S, Bandyopadhyay D, Patro BK, Khan S, Naik S. Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial. Complement Ther Med. 2020;53:102526. https://doi.org/10.1016/j.ctim.2020.102526.

17. Fu Y, Zhu Z, Huang Z, He R, Zhang Y, Li Y et al. Association between Vitamin B and Obesity in Middle-Aged and Older Chinese Adults. Nutrients. 2023;15(3):483. https://doi.org/10.3390/nu15030483.

18. Baltaci D, Kutlucan A, Öztürk S, Karabulut I, Yildirim HA, Celer A et al. Evaluation of vitamin B-12 level in middle-aged obese women with metabolic and non-metabolic syndrome: Case-control study. Turk J Med Sci. 2012;42(5):802–809. https://doi.org/10.3906/sag-1105-6.

19. Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann Neurol. 2010;68(4):503–510. https://doi.org/10.1002/ana.22189.